Drugs / Neoantigen-expanded cell therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05020119 | Apr 2021 → Jun 2022 | neoplasm | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neoantigen-expanded cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05020119 ↗ |
| Modality | Cell therapy | “autologous immune cell therapy” NCT05020119 ↗ |